Zobrazeno 1 - 5
of 5
pro vyhledávání: '"David E. Goldgar"'
Autor:
Alexandre Sibert, David E. Goldgar
Publikováno v:
Familial Cancer; Jan2003, Vol. 2 Issue 1, p35-42, 8p
Autor:
Rachel McFarland, Shuwei Li, Jill S. Dolinsky, Mary Pritzlaff, Pia Summerour, Elizabeth C. Chao, David E. Goldgar, Fergus J. Couch, Hermela Shimelis, Patrick Reineke, Holly LaDuca
Publikováno v:
Breast Cancer Research and Treatment
Pritzlaff, Mary; Summerour, Pia; McFarland, Rachel; Li, Shuwei; Reineke, Patrick; Dolinsky, Jill S; et al.(2017). Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results.. Breast cancer research and treatment, 161(3), 575-5586. UC Irvine: Institute for Clinical and Translational Science. Retrieved from: http://www.escholarship.org/uc/item/6n16d1bp
Pritzlaff, Mary; Summerour, Pia; McFarland, Rachel; Li, Shuwei; Reineke, Patrick; Dolinsky, Jill S; et al.(2017). Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results.. Breast cancer research and treatment, 161(3), 575-5586. UC Irvine: Institute for Clinical and Translational Science. Retrieved from: http://www.escholarship.org/uc/item/6n16d1bp
Purpose Genetic predisposition to male breast cancer (MBC) is not well understood. The aim of this study was to better define the predisposition genes contributing to MBC and the utility of germline multi-gene panel testing (MGPT) for explaining the
Autor:
Letitia D. Smith, Irene L. Andrulis, Ee Ming Wong, Andrew K. Godwin, Andrea Tesoriero, Esther M. John, Mary B. Daly, Mary Beth Terry, Ruby T. Senie, Stephen B. Fox, Melissa C. Southey, David E. Goldgar, Frances P. O'Malley, Graham G. Giles, Saundra S. Buys, Regina M. Santella, Hilmi Ozcelik, John L. Hopper, Anna Marie Mulligan, Susan J. Ramus
Publikováno v:
Breast Cancer Research : BCR
Introduction: Selecting women affected with breast cancer who are most likely to carry a germline mutation in BRCA1 and applying the most appropriate test methodology remains challenging for cancer genetics services. We sought to test the value of se
Autor:
E. B. Gómez-García, David E. Goldgar, Amanda B. Spurdle, C. H. H. Kerkhofs, Patrick J. Lindsey
Publikováno v:
Hereditary Cancer in Clinical Practice
Hereditary Cancer in Clinical Practice, 14:10. BioMed Central
Hereditary Cancer in Clinical Practice, 14:10. BioMed Central
Purpose One way of evaluating family history (FH) for classifying BRCA1/2 variants of uncertain clinical significance (VUS) is to assess the “BRCA-ness” of a pedigree by comparing it to reference populations. The aim of this study was to assess i
Autor:
Ana Osorio, Juan Manuel Rosa-Rosa, Emilio González, Olga M. Sinilnikova, Henry T. Lynch, Javier Benitez, Guillermo Pita, Peter Devilee, Melissa C. Southey, Anna González-Neira, David E. Goldgar, Christi J. van Asperen, Nicoline Hoogerbrugge, Rogier A. Oldenburg
Publikováno v:
BMC Genomics
BMC Genomics, Vol 8, Iss 1, p 299 (2007)
BMC Genomics, Vol 8, Iss 1, p 299 (2007)
Background The recent development of new high-throughput technologies for SNP genotyping has opened the possibility of taking a genome-wide linkage approach to the search for new candidate genes involved in heredity diseases. The two major breast can